|Videos|July 14, 2015
Ticagrelor May Reduce Subsequent Myocardial Infarction Risk
Advertisement
Episodes in this series
Similar to the
Researchers studied nearly 20,000 patients who had a myocardial infarction (MI) 1 to 3 years prior, plus 1 additional cardiovascular risk factor, to see how they managed on ticagrelor beyond 12 months.
Patients were given 60 mg or 90 mg of ticagrelor, or placebo. The researchers determined both ticagrelor dosage strengths reduced the risk of subsequent MI, notes Yekaterina Opsha, PharmD, BCPS-AQ Cardiology, a clinical specialist of cardiovascular medicine at Saint Barnabas Medical Center.
Advertisement
Related to this article
The randomized ALLIANCE A051701 trial closed early when treatment-related toxicity and mortality were increased without improving PFS in patients with newly diagnosed double-hit lymphoma.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
Robin Tumlinson, PharmD, BCOP, discusses how rapidly expanding bladder cancer options are creating new questions around treatment sequencing, toxicity management, biomarker testing, and multidisciplinary care.
With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
A prospective observational study found microplastics more frequently and at higher levels in lung samples from patients with lung malignancies, although the findings do not establish that the particles cause cancer.
Helicobacter pylori exposure could be associated with approximately 22% of colorectal cancer cases worldwide.
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
2
Beyond Cost Avoidance: Advancing Unit-Level Pharmaceutical Economics in Health Systems
3
Pharmacists' Role as Ketone Monitoring Reaches Clinics
4
From Reactive to Proactive: AI's Role in Modern Pharmacy Safety
5